Literature DB >> 19464056

Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.

Yukihiro Akao1, Yoshihito Nakagawa, Akio Iio, Tomoki Naoe.   

Abstract

Treatment of Jurkat T cells with Fas-activating antibody (CH-11) facilitated rapid cell death that was shown to be caspase-dependent apoptosis. The expression of miR-143 was up-regulated during the apoptosis with time. The increased expression of miR-143 emerged from 1 to 2h after the treatment, at which time the caspases-8 and -3 were also activated; and this increase was almost canceled by the pretreatment with an inhibitor of caspase-3 or -8. Furthermore, the transfection of Jurkat cells with mature miR-143 induced a significant growth suppression and enhancement of CH-11-induced apoptosis. On the contrary, an extracellular signal-regulated protein kinase 5 (ERK5), which was determined to be a target of miR-143 in colon cancer DLD-1 cells, was time-dependently down-regulated at the translational level after the treatment. During the apoptosis, the expression level of FasL was maintained and the level of nuclear-Foxo3a was increased in the early phase. These data suggest that the up-regulation of miR-143 could be related to the apoptosis in part by targeting ERK5, which leads to promotion of Foxo3a/FasL positive feedback loop.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464056     DOI: 10.1016/j.leukres.2009.04.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  35 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

2.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

Review 3.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 4.  Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Authors:  Juliana Inês Santos; Ana Luísa Teixeira; Francisca Dias; Mónica Gomes; Augusto Nogueira; Joana Assis; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-25

5.  Meta-analysis of microRNA expression profiling studies in human cervical cancer.

Authors:  Mei-Yi Li; Xiao-Xia Hu
Journal:  Med Oncol       Date:  2015-04-24       Impact factor: 3.064

6.  Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.

Authors:  Ntube N O Ngalame; Ngome L Makia; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-22       Impact factor: 4.219

7.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

8.  MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.

Authors:  Feng Xue; Jiwei Yin; Lin Xu; Boqing Wang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

9.  Identification of non-coding RNAs embracing microRNA-143/145 cluster.

Authors:  Akio Iio; Yoshihito Nakagawa; Ichiro Hirata; Tomoki Naoe; Yukihiro Akao
Journal:  Mol Cancer       Date:  2010-06-02       Impact factor: 27.401

10.  MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.

Authors:  Yue-Ping Zeng; Giang Huong Nguyen; Hong-Zhong Jin
Journal:  Mol Cell Biochem       Date:  2016-04-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.